Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07564297 · ClinicalTrials.gov registry record
North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia
A clinical trial, sponsored by Mayo Clinic.
- Not yet
- Registry status
- 80
- Enrollment target
NCT07564297: Clinical Trial study, sponsored by Mayo Clinic.
NCT07564297 is a clinical trial that has not yet begun recruiting, run by Mayo Clinic. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07564297 has not yet begun recruiting, sponsored by Mayo Clinic.
- NOT YET RECRUITING
- Registry status
- 80 participants
- Enrollment target
Study Summary
The purpose of this research is to determine if babies who undergo a Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure survive more often and have less long-term complications than babies who have similarly severe Congenital Diaphragmatic Hernia (CDH) that have not had the FETO procedure performed during pregnancy
Interventions
- OTHER Standard of Care
- DEVICE Fetoscopic Endoluminal Tracheal Occlusion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2038-05-31 |
What is known before NCT07564297 opens enrollment
NCT07564297 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 80 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT07564297 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07564297 about?
NCT07564297 is a clinical study titled "North American Fetal Therapy Network Prospective Registry for Long-term Outcome Following Fetoscopic Endoluminal Tracheal Occlusion in Severe Left and Right Congenital Diaphragmatic Hernia". The purpose of this research is to determine if babies who undergo a Fetoscopic Endoluminal Tracheal Occlusion (FETO) procedure survive more often and have less long-term complications than babies who have similarly severe Congenital Diaphragmatic Hernia (CDH) that have not had the FETO procedure pe...
What is the current status of trial NCT07564297?
This trial is currently not yet recruiting. The enrollment target is 80 participants. The study started on 2026-06-01. Estimated completion is 2038-05-31.
What interventions are being tested in trial NCT07564297?
The interventions under investigation include: Standard of Care (OTHER), Fetoscopic Endoluminal Tracheal Occlusion (DEVICE).
Who is sponsoring clinical trial NCT07564297?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI